Roche Enters Cancer Treatment Alliance with Molecular Partners (Source: DrugDiscovery&Development)

Roche and Molecular Partners AG announced that they have entered into a research collaboration and licensing agreement to discover, develop and commercialize several proprietary therapeutics incorporating Molecular Partners’ DARPin biologics conjugated...

Celgene commits $3.3B in whopper cancer stem cell deal with OncoMed (Source: Fierce Biotech)

Celgene helped seal its reputation as one of the boldest dealmakers in biotech today, putting up $177.25 million in an upfront fee and equity stake while committing to more than $3...

Sanofi touts promising PhIII data on next-gen diabetes therapy as rivals circle (Source: Fierce...

Sanofi ($SNY) has peeled back the cover on another chapter of Phase III data for U300, advancing its case that its next-gen diabetes therapy can be safer and just as effective...

EMD Serono Creates Spin-Off Company for Infertility Treatment (Source: DrugDiscovery&Development)

EMD Serono Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, announced the creation of TocopheRx, a Boston-based spin-off company resulting from the Entrepreneur Partnership Program (EPP) launched by Merck Serono, the...

GSK Builds Academic Partnership in Epigenetic Drug Discovery (Source: DrugDiscovery&Development)

Cancer Research Technology, the commercial arm of Cancer Research UK, and the University of Manchester announced a research agreement with GlaxoSmithKline (GSK) to generate new cancer drugs in the field of...

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

WUXI NEWS

Life Science Leaders Celebrate Global Partnerships During WuXi Global Forum 2018

More than 2,000 life science industry insiders around the globe participated in the WuXi Global Forum on Jan. 9, 2018 during the annual J.P....

WuXi Global Forum 2018